Drug intelligence / Profile preview

Visine

Development stage
Approved
Lead developer
Kenvue
Administration
Ophthalmic
01

Overview

**Visine** is a non-specific over-the-counter ophthalmic product brand rather than one defined drug substance. The brand includes redness-relief, allergy-relief, lubricating dry-eye, and multi-symptom eye-drop formulations with different active-ingredient compositions. For example, the classic redness-relief formulation contains tetrahydrozoline hydrochloride, an imidazoline sympathomimetic that constricts superficial conjunctival blood vessels; other Visine products are lubricant formulations or contain additional allergy-relief agents. The provided 2016 study evaluated a specific prototype lubricant formulation containing glycerin, hypromellose, polyethylene glycol 400, and polyquaternium-42 preservative, not every product marketed under the Visine name. Visine is currently a Kenvue consumer-health brand. ([visine.com](https://www.visine.com/))

Brand names
Visine
02

Targets

ADRA1A (α1A)

Beyond the preview

Go deeper on Visine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Visine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call